The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...
Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...
KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback